Omega-3: Fish Oil, Krill, Algal — Which Form Actually Works
Key takeaways Strongest evidence: modest triglyceride reduction (25–30% with 2–4 g/day EPA+DHA) and reduced cardiovascular events in secondary prevention at prescription doses — FDA has approved icosapent ethyl (EPA-only, 4 g) after the REDUCE-IT trial. For primary prevention of heart disease in the general population, effects are modest at best — a large Cochrane review … Read more